Orexo AB Total Liabilities

Latest as of June 2026: Skr243.30 Million SEK ≈ $26.18 Million USD

Orexo AB total liabilities. Based on the latest financial reports, Orexo AB (ORX) has total liabilities worth Skr243.30 Million SEK (≈ $26.18 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ORX financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Orexo AB (2002–2025)

Total liabilities of Orexo AB from 2002 to 2025. This chart illustrates how Orexo AB's total liabilities have evolved over time, based on quarterly financial data. Explore ORX strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

Orexo AB Competitors by Total Liabilities

The table below lists competitors of Orexo AB ranked by their total liabilities.

Company	Country	Total Liabilities
NCC Group plc LSE:NCC	UK	GBX136.80 Million
Garanti Yatirim Ortakligi AS IS:GRNYO	Turkey	TL4.55 Million
Westbond Enterprises Corp V:WBE	Canada	CA$4.47 Million
Homebiogas Ltd TA:HMGS	Israel	ILA2.20 Million
Nanologica AB ST:NICA	Sweden	Skr164.82 Million
Hiremii Ltd AU:HMI	Australia	AU$4.74 Million
Utilico Emerging Markets Ltd LSE:UEM	UK	GBX25.52 Million
ECS Botanics Holdings Ltd AU:ECS	Australia	AU$9.11 Million

Liability Composition Analysis (2002–2025)

This chart breaks down Orexo AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Orexo AB.

Liquidity & Leverage Metrics

Orexo AB Total Liabilities Ratios Explained

Orexo AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.65	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.90	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.47	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Orexo AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Orexo AB (2002–2025)

The table below shows the annual total liabilities of Orexo AB from 2002 to 2025.

Year	Total Liabilities	Change
2025-12-31	Skr812.20 Million ≈ $87.41 Million	+12.63%
2024-12-31	Skr721.10 Million ≈ $77.60 Million	-0.91%
2023-12-31	Skr727.70 Million ≈ $78.31 Million	-20.48%
2022-12-31	Skr915.10 Million ≈ $98.48 Million	-0.97%
2021-12-31	Skr924.10 Million ≈ $99.45 Million	+37.03%
2020-12-31	Skr674.40 Million ≈ $72.58 Million	-15.14%
2019-12-31	Skr794.70 Million ≈ $85.52 Million	-1.96%
2018-12-31	Skr810.60 Million ≈ $87.23 Million	+20.12%
2017-12-31	Skr674.80 Million ≈ $72.62 Million	-4.76%
2016-12-31	Skr708.50 Million ≈ $76.25 Million	-5.51%
2015-12-31	Skr749.85 Million ≈ $80.70 Million	-2.73%
2014-12-31	Skr770.86 Million ≈ $82.96 Million	+26.19%
2013-12-31	Skr610.87 Million ≈ $65.74 Million	+110.24%
2012-12-31	Skr290.56 Million ≈ $31.27 Million	+23.64%
2011-12-31	Skr235.00 Million ≈ $25.29 Million	-3.87%
2010-12-31	Skr244.45 Million ≈ $26.31 Million	+142.82%
2009-12-31	Skr100.67 Million ≈ $10.83 Million	-23.87%
2008-12-31	Skr132.24 Million ≈ $14.23 Million	+1.24%
2007-12-31	Skr130.62 Million ≈ $14.06 Million	+135.01%
2006-12-31	Skr55.58 Million ≈ $5.98 Million	+71.54%
2005-12-31	Skr32.40 Million ≈ $3.49 Million	+21.90%
2004-12-31	Skr26.58 Million ≈ $2.86 Million	+186.74%
2003-12-31	Skr9.27 Million ≈ $997.60K	+19.91%
2002-12-31	Skr7.73 Million ≈ $831.98K	--

About Orexo AB

ST:ORX Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$5.66 Million

Skr52.62 Million SEK

Market Cap Rank

#28257 Global

#619 in Sweden

Share Price

Skr1.50

Change (1 day)

-64.38%

52-Week Range

Skr1.50 - Skr35.75

All Time High

Skr85.70